3976 - 4000 of 9156 Results
Title
Year
- Detection of oligomeric forms of α‐synuclein protein in human plasma as a potential biomarker for Parkinson's disease2006RESTRICTEDTitle: Detection of oligomeric forms of α‐synuclein protein in human plasma as a potential biomarker for Parkinson's diseaseJournal Name: The FASEB JournalPublisher: WileyVol: 20Issue #: 3Start Page: 419End Page: 425Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fj.03-1449comCitation Count: 709
- Extent of Inhibition of α-Synuclein Aggregation in Vitro by SUMOylation Is Conjugation Site- and SUMO Isoform-Selective2015RESTRICTEDTitle: Extent of Inhibition of α-Synuclein Aggregation in Vitro by SUMOylation Is Conjugation Site- and SUMO Isoform-SelectiveJournal Name: BiochemistryPublisher: American Chemical Society (ACS)Vol: 54Issue #: 4Start Page: 959End Page: 961Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/bi501512mCitation Count: 65
-
OPENTitle: NEAT1 is overexpressed in Parkinson's disease substantia nigra and confers drug‐inducible neuroprotection from oxidative stressJournal Name: The FASEB JournalPublisher: WileyVol: 33Issue #: 10Start Page: 11223End Page: 11234Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1096/fj.201900830rBest OA location URL: https://doi.org/10.1096/fj.201900830rCitation Count: 129
-
OPENTitle: Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 17Issue #: 1Start Page: 64End Page: 74Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(17)30400-3Best OA location URL: https://kclpure.kcl.ac.uk/ws/files/148223504/Investigating_the_genetic_architecture_of_dementia_TROAKES_Publishedonline16December2017_GREEN_AAM.pdfCitation Count: 292
-
OPENTitle: A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 11Issue #: 514Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aau6870Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7359409Citation Count: 106
-
OPENTitle: Characterization of extracellular vesicles and synthetic nanoparticles with four orthogonal single‐particle analysis platformsJournal Name: Journal of Extracellular VesiclesPublisher: WileyVol: 10Issue #: 6Start Page: e12079End Page: e12079Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/jev2.12079Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jev2.12079Citation Count: 220
- Aromatic L‐Amino Acid Decarboxylase Gene Therapy Enhances Levodopa Response in Parkinson's Disease2020OPENTitle: Aromatic L‐Amino Acid Decarboxylase Gene Therapy Enhances Levodopa Response in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 5Start Page: 851End Page: 858Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27993Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27993Citation Count: 52
-
OPENTitle: Decision-Making Deficits Associated with Amyloidosis in Lewy Body DisordersJournal Name: Frontiers in Human NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page: 693End Page: 693Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnhum.2016.00693Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnhum.2016.00693/pdfCitation Count: 3
- Alpha Synuclein Fibrils Contain Multiple Binding Sites for Small Molecules2018RESTRICTEDTitle: Alpha Synuclein Fibrils Contain Multiple Binding Sites for Small MoleculesJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 9Issue #: 11Start Page: 2521End Page: 2527Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.8b00177Citation Count: 84
-
OPENTitle: Ultra‐low‐dose PET reconstruction using generative adversarial network with feature matching and task‐specific perceptual lossJournal Name: Medical PhysicsPublisher: WileyVol: 46Issue #: 8Start Page: 3555End Page: 3564Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mp.13626Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6692211Citation Count: 184
-
OPENTitle: Dying-back of ascending noradrenergic projections in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 144Issue #: 9Start Page: 2562End Page: 2564Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awab286Best OA location URL: https://academic.oup.com/brain/article-pdf/144/9/2562/40880422/awab286.pdfCitation Count: 8
- Current status of the development of PET radiotracers for imaging alpha synuclein aggregates in Lewy bodies and Lewy neurites2016RESTRICTEDTitle: Current status of the development of PET radiotracers for imaging alpha synuclein aggregates in Lewy bodies and Lewy neuritesJournal Name: Clinical and Translational ImagingPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page: 3End Page: 14Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40336-016-0217-4Citation Count: 50
-
OPENTitle: Surgical Correction of Pes Equinovarus in People With Stroke: Effects on Personalized Goal Attainment and Balance and Gait CapacityJournal Name: Archives of Physical Medicine and RehabilitationPublisher: Elsevier BVVol: 107Issue #: 6Start Page: 1364End Page: 1370Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.apmr.2026.01.015Best OA location URL: https://doi.org/10.1016/j.apmr.2026.01.015Citation Count: 0
-
OPENTitle: Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble α-synuclein in neuronsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 111Issue #:Start Page: 26End Page: 35Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2017.12.005Best OA location URL: https://doaj.org/article/fd9888c9cbe94f60a22d9ed0b3ff97d3Citation Count: 145
-
OPENTitle: Bundled Three-Dimensional Human Axon Tracts Derived from Brain OrganoidsJournal Name: iSciencePublisher: Elsevier BVVol: 21Issue #:Start Page: 57End Page: 67Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.isci.2019.10.004Best OA location URL: http://www.cell.com/article/S2589004219303839/pdfCitation Count: 54
-
RESTRICTEDTitle: Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson’s diseaseJournal Name: Journal of Experimental MedicinePublisher: Rockefeller University PressVol: 213Issue #: 9Start Page: 1759End Page: 1778Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1084/jem.20160368Best OA location URL: http://doi.org/10.1084/jem.20160368Citation Count: 404
- Tandem Mass Spectrometry Multiplex Analysis of Glucosylceramide and Galactosylceramide Isoforms in Brain Tissues at Different Stages of Parkinson Disease2016RESTRICTEDTitle: Tandem Mass Spectrometry Multiplex Analysis of Glucosylceramide and Galactosylceramide Isoforms in Brain Tissues at Different Stages of Parkinson DiseaseJournal Name: Analytical ChemistryPublisher: American Chemical Society (ACS)Vol: 88Issue #: 3Start Page: 1856End Page: 1863Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.analchem.5b04227Citation Count: 83
-
OPENTitle: Discovery of Volatile Biomarkers of Parkinson’s Disease from SebumJournal Name: ACS Central SciencePublisher: American Chemical Society (ACS)Vol: 5Issue #: 4Start Page: 599End Page: 606Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acscentsci.8b00879Best OA location URL: https://doi.org/10.1021/acscentsci.8b00879Citation Count: 175
-
OPENTitle: Dynamics of PARKIN-Dependent Mitochondrial Ubiquitylation in Induced Neurons and Model Systems Revealed by Digital Snapshot ProteomicsJournal Name: Molecular CellPublisher: Elsevier BVVol: 70Issue #: 2Start Page: 211End Page: 227.e8Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.molcel.2018.03.012Best OA location URL: http://www.cell.com/article/S1097276518302156/pdfCitation Count: 199
-
OPENTitle: Association between different diabetes medication classes and risk of Parkinson's disease in people with diabetesJournal Name: Pharmacoepidemiology and Drug SafetyPublisher: WileyVol: 31Issue #: 8Start Page: 875End Page: 882Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/pds.5448Best OA location URL: https://doi.org/10.1002/pds.5448Citation Count: 19
- Stress and Mindfulness in Parkinson's Disease: Clinical Effects and Potential Underlying Mechanisms2020OPENTitle: Stress and Mindfulness in Parkinson's Disease: Clinical Effects and Potential Underlying MechanismsJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 64End Page: 70Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28345Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28345Citation Count: 75
-
OPENTitle: Anxiety in Parkinson's disease is associated with changes in the brain fear circuitJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 80Issue #:Start Page: 89End Page: 97Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.09.020Best OA location URL: http://www.prd-journal.com/article/S1353802020307343/pdfCitation Count: 37
- Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects2014RESTRICTEDTitle: Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjectsJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 571Issue #:Start Page: 34End Page: 38Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2014.04.027Best OA location URL: http://doi.org/10.1016/j.neulet.2014.04.027Citation Count: 141
- Guanabenz promotes neuronal survival via enhancement of ATF4 and parkin expression in models of Parkinson disease2018RESTRICTEDTitle: Guanabenz promotes neuronal survival via enhancement of ATF4 and parkin expression in models of Parkinson diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 303Issue #:Start Page: 95End Page: 107Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2018.01.015Citation Count: 44
-
OPENTitle: Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primatesJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 6Issue #: 20Start Page: eaaz9165End Page: eaaz9165Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/sciadv.aaz9165Best OA location URL: https://advances.sciencemag.org/content/advances/6/20/eaaz9165.full.pdfCitation Count: 61